BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 30538445)

  • 1. Evaluating the impact of morning symptoms in COPD using the Capacity of Daily Living during the Morning (CDLM) questionnaire.
    Núñez A; Esquinas C; Barrecheguren M; Calle M; Casamor R; Miravitlles M
    Int J Chron Obstruct Pulmon Dis; 2018; 13():3837-3844. PubMed ID: 30538445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The association between objectively measured physical activity and morning symptoms in COPD.
    van Buul AR; Kasteleyn MJ; Chavannes NH; Taube C
    Int J Chron Obstruct Pulmon Dis; 2017; 12():2831-2840. PubMed ID: 29042764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and validation of the Capacity of Daily Living during the Morning questionnaire and the Global Chest Symptoms Questionnaire in COPD.
    Partridge MR; Miravitlles M; Ståhl E; Karlsson N; Svensson K; Welte T
    Eur Respir J; 2010 Jul; 36(1):96-104. PubMed ID: 19897551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence and impact of respiratory symptoms in a population of patients with COPD in Latin America: The LASSYC observational study.
    Miravitlles M; Menezes A; López Varela MV; Casas A; Ugalde L; Ramirez-Venegas A; Mendoza L; López A; Wehrmeister FC; Surmont F; Montes de Oca M
    Respir Med; 2018 Jan; 134():62-69. PubMed ID: 29413510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Cross-Sectional Study in Patients with Severe COPD to Assess the Perception of Symptom Variability (COPVAR) in the Middle East and Africa.
    Kokturk N; Abuharbid W; Albanna AS; Gunen H; Gurgun A; Khadadah M; Malvolti E; Soliman M; van Zyl-Smit R; Zidouni N; Alzaabi A
    Int J Chron Obstruct Pulmon Dis; 2019; 14():2959-2970. PubMed ID: 31908444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Observational study to characterise 24-hour COPD symptoms and their relationship with patient-reported outcomes: results from the ASSESS study.
    Miravitlles M; Worth H; Soler Cataluña JJ; Price D; De Benedetto F; Roche N; Godtfredsen NS; van der Molen T; Löfdahl CG; Padullés L; Ribera A
    Respir Res; 2014 Oct; 15(1):122. PubMed ID: 25331383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The chronic obstructive pulmonary disease assessment test improves the predictive value of previous exacerbations for poor outcomes in COPD.
    Miravitlles M; García-Sidro P; Fernández-Nistal A; Buendía MJ; Espinosa de Los Monteros MJ; Esquinas C; Molina J
    Int J Chron Obstruct Pulmon Dis; 2015; 10():2571-9. PubMed ID: 26664105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Respiratory Symptoms Items from the COPD Assessment Test Identify Ever-Smokers with Preserved Lung Function at Higher Risk for Poor Respiratory Outcomes. An Analysis of the Subpopulations and Intermediate Outcome Measures in COPD Study Cohort.
    Martinez CH; Murray S; Barr RG; Bleecker E; Bowler RP; Christenson SA; Comellas AP; Cooper CB; Couper D; Criner GJ; Curtis JL; Dransfield MT; Hansel NN; Hoffman EA; Kanner RE; Kleerup E; Krishnan JA; Lazarus SC; Leidy NK; O'Neal W; Martinez FJ; Paine R; Rennard SI; Tashkin DP; Woodruff PG; Han MK;
    Ann Am Thorac Soc; 2017 May; 14(5):636-642. PubMed ID: 28459622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and distribution of COPD phenotypes in clinical practice according to Spanish COPD Guidelines: the FENEPOC study.
    Calle Rubio M; Casamor R; Miravitlles M
    Int J Chron Obstruct Pulmon Dis; 2017; 12():2373-2383. PubMed ID: 28848338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Impact of chronic obstructive pulmonary disease on activities of daily living: results of the EIME multicenter study].
    Alvarez-Gutiérrez FJ; Miravitlles M; Calle M; Gobartt E; López F; Martín A;
    Arch Bronconeumol; 2007 Feb; 43(2):64-72. PubMed ID: 17288894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Depressive status explains a significant amount of the variance in COPD assessment test (CAT) scores.
    Miravitlles M; Molina J; Quintano JA; Campuzano A; Pérez J; Roncero C;
    Int J Chron Obstruct Pulmon Dis; 2018; 13():823-831. PubMed ID: 29563782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Different impacts of respiratory symptoms and comorbidities on COPD-specific health-related quality of life by COPD severity.
    Lee H; Jhun BW; Cho J; Yoo KH; Lee JH; Kim DK; Lee JD; Jung KS; Lee JY; Park HY
    Int J Chron Obstruct Pulmon Dis; 2017; 12():3301-3310. PubMed ID: 29180860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of night-time symptoms in COPD: a real-world study in five European countries.
    Price D; Small M; Milligan G; Higgins V; Gil EG; Estruch J
    Int J Chron Obstruct Pulmon Dis; 2013; 8():595-603. PubMed ID: 24348032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical variables impacting on the estimation of utilities in chronic obstructive pulmonary disease.
    Miravitlles M; Huerta A; Valle M; García-Sidro P; Forné C; Crespo C; López-Campos JL
    Int J Chron Obstruct Pulmon Dis; 2015; 10():367-77. PubMed ID: 25733826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Self-reported daily walking time in COPD: relationship with relevant clinical and functional characteristics.
    Ramon MA; Esquinas C; Barrecheguren M; Pleguezuelos E; Molina J; Quintano JA; Roman-Rodríguez M; Naberan K; Llor C; Roncero C; Miravitlles M
    Int J Chron Obstruct Pulmon Dis; 2017; 12():1173-1181. PubMed ID: 28458527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The COPD assessment test and St George's Respiratory Questionnaire: are they equivalent in subjects with COPD?
    Morishita-Katsu M; Nishimura K; Taniguchi H; Kimura T; Kondoh Y; Kataoka K; Ogawa T; Watanabe F; Arizono S; Nishiyama O; Nakayasu K; Imaizumi K; Hasegawa Y
    Int J Chron Obstruct Pulmon Dis; 2016; 11():1543-51. PubMed ID: 27462150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modified Medical Research Council scale vs Baseline Dyspnea Index to evaluate dyspnea in chronic obstructive pulmonary disease.
    Perez T; Burgel PR; Paillasseur JL; Caillaud D; Deslée G; Chanez P; Roche N;
    Int J Chron Obstruct Pulmon Dis; 2015; 10():1663-72. PubMed ID: 26316740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The CAT (COPD Assessment Test) questionnaire as a predictor of the evolution of severe COPD exacerbations.
    García-Sidro P; Naval E; Martinez Rivera C; Bonnin-Vilaplana M; Garcia-Rivero JL; Herrejón A; Malo de Molina R; Marcos PJ; Mayoralas-Alises S; Ros JA; Valle M; Esquinas C; Barrecheguren M; Miravitlles M
    Respir Med; 2015 Dec; 109(12):1546-52. PubMed ID: 26542727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact and factors associated with nighttime and early morning symptoms among patients with chronic obstructive pulmonary disease.
    Stephenson JJ; Cai Q; Mocarski M; Tan H; Doshi JA; Sullivan SD
    Int J Chron Obstruct Pulmon Dis; 2015; 10():577-86. PubMed ID: 25844033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Symptoms and impact of COPD assessed by an electronic diary in patients with moderate-to-severe COPD: psychometric results from the SHINE study.
    Kulich K; Keininger DL; Tiplady B; Banerji D
    Int J Chron Obstruct Pulmon Dis; 2015; 10():79-94. PubMed ID: 25609942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.